Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Anbio Biotechnology (NNNN : NSDQ)

• Company Description    Anbio Biotechnology is a diagnostic company dedicated to the advancement of medical technology and the provision of in vitro diagnostics products. Anbio Biotechnology is based in Frankfurt am Main, Germany. Number of Employees: 27

• Price / Volume Information    Yesterday's Closing Price: $32.52 Daily Weekly Monthly 20 Day Moving Average: 23,520 shares Shares Outstanding: 143.89 (millions) Market Capitalization: $4,679.34 (millions) Beta: 4.71 52 Week High: $55.65 52 Week Low: $7.23 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 19.25% 13.43% 12 Week 18.04% 9.12% Year To Date 8.15% -7.51%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL WILHELM GUTBROD STR 21B - FRANKFURT AM MAIN,2M 60437 DEU ph: 49-1609-624-7281 fax: - None http://www.anbio.com

• General Corporate Information    Officers Michael Lau - Chief Executive Officer Suki Song - Chief Financial Officer Cany Xu - Director Chris Tian - Director Nancy Hartzler - Director Peer Information Anbio Biotechnology (CORR.) Anbio Biotechnology (RSPI) Anbio Biotechnology (CGXP) Anbio Biotechnology (BGEN) Anbio Biotechnology (GTBP) Anbio Biotechnology (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: G0367B105 SIC: 2835 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: 07/07/26 Share - Related Items Shares Outstanding: 143.89 Most Recent Split Date: (:1) Beta: 4.71 Market Capitalization: $4,679.34 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 07/07/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 155.17 Price/Cash Flow: 730.69 Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/26 - - 12/31/25 - - 09/30/25 - - ROA 03/31/26 - - 12/31/25 - - 09/30/25 - - Current Ratio 03/31/26 - - 12/31/25 - 344.31 09/30/25 - - Quick Ratio 03/31/26 - - 12/31/25 - 344.31 09/30/25 - - Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Pre-Tax Margin 03/31/26 - - 12/31/25 - 74.05 09/30/25 - - Book Value 03/31/26 - - 12/31/25 - 0.21 09/30/25 - - Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - - 12/31/25 - 0.00 09/30/25 - - Debt-to-Capital 03/31/26 - - 12/31/25 - 0.00 09/30/25 - -

Powered by Zacks Investment Research ©